Why the study?
Does A116C Angiotensin II Type 1 Receptor Gene Polymorphism predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension?
Does A116C Angiotensin II Type 1 Receptor Gene Polymorphism predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension?
Answers are grounded in this paper and cite their sources.
The A116C Angiotensin II Type 1 Receptor Gene Polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Spiering et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: